Skip to main content
Equibles

George M. Jenkins

Chairman

Palvella Therapeutics, Inc. (PVLA)

Board Member

Palvella Therapeutics, Inc. (PVLA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Palvella Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get PVLA alerts

About George M. Jenkins

George M. Jenkins is recorded as Chairman at Palvella Therapeutics, Inc. (PVLA) since December 13, 2024 and Board Member at Palvella Therapeutics, Inc. (PVLA) since January 1, 2024. The newest filing on record that lists George M. Jenkins as Board Member at Palvella Therapeutics, Inc. (PVLA) is dated April 30, 2026. Palvella Therapeutics, Inc. reported in an 8-K filed June 16, 2026 that George M. Jenkins was appointed Class III director, effective June 10, 2026. Palvella Therapeutics, Inc. reported in an 8-K filed December 16, 2024 that George M. Jenkins was appointed Chairman of the Board, effective December 13, 2024. Palvella Therapeutics, Inc. reported in an 8-K filed December 16, 2024 that George M. Jenkins was appointed Director, effective December 13, 2024. Palvella Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Palvella Therapeutics, Inc. includes Wesley H. Kaupinen (CEO and Board Member), James Geraghty (Chairman), Matthew E. Korenberg (CFO) and 7 others.

“George M. Jenkins, Todd C. Davis and John Doux, M.D. were elected to the Board as Class III directors to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors, if any, are duly elected and qualified or appointed, or their earlier death, resignation, retirement, disqualification or removal, as follows:”
Palvella Therapeutics, Inc. Form 8-K, filed June 16, 2026 · Read the filing
“In connection with the Merger and pursuant to the Merger Agreement, at the Effective Time, the following individuals were appointed to serve as executive officers and directors of the Company: George M. Jenkins | 72 | Chairman of the Board”
Palvella Therapeutics, Inc. Form 8-K, filed December 16, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Palvella Therapeutics, Inc.

Recent activity